{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T04:55:46Z","timestamp":1780635346180,"version":"3.54.1"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CE"],"DOI":"10.2147\/ce.s5992","type":"journal-article","created":{"date-parts":[[2010,9,14]],"date-time":"2010-09-14T23:51:22Z","timestamp":1284508282000},"page":"181","source":"Crossref","is-referenced-by-count":8,"title":["Tocilizumab: The evidence for its place in the treatment of juvenile idiopathic arthritis"],"prefix":"10.2147","author":[{"given":"Troels","family":"Herlin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2009,8]]},"container-title":["Core Evidence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=5144","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T22:03:16Z","timestamp":1477864996000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dovepress.com\/tocilizumab-the-evidence-for-its-place-in-the-treatment-of-juvenile-id-peer-reviewed-article-CE"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/ce.s5992","relation":{},"ISSN":["1555-175X"],"issn-type":[{"value":"1555-175X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}